Ruth Young, Joseph Ssekasanvu, Joseph Kagaayi, Robert Ssekubugu, Godfrey Kigozi, Steven J Reynolds, Bareng A S Nonyane, Larry W Chang, Caitlin E Kennedy, Ligia Paina, Philip A Anglewicz, Thomas C Quinn, David Serwadda, Fred Nalugoda, M Kate Grabowski
{"title":"HIV and viremia prevalence in non-migrating members of migrant households in southern Uganda: A cross-sectional population-based study.","authors":"Ruth Young, Joseph Ssekasanvu, Joseph Kagaayi, Robert Ssekubugu, Godfrey Kigozi, Steven J Reynolds, Bareng A S Nonyane, Larry W Chang, Caitlin E Kennedy, Ligia Paina, Philip A Anglewicz, Thomas C Quinn, David Serwadda, Fred Nalugoda, M Kate Grabowski","doi":"10.1097/QAI.0000000000003553","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>In Africa, migrants are more likely to be living with HIV and HIV viremic than non-migrants but less is known about HIV outcomes among non-migrants living in households with migrants. We compared HIV outcomes in non-migrating persons in households with and without migration.</p><p><strong>Methods: </strong>We analyzed cross-sectional data collected between August 2016-May 2018 from non-migrating participants aged 15-49 in the Rakai Community Cohort Study in Uganda. Migrant households were classified as those reporting ≥1 member moving into or out of the household since the prior survey. HIV serostatus was determined using a validated testing algorithm, and viremia defined as >1,000 copies/mL. Modified Poisson regression was used to estimate prevalence ratios (PR) between household migration and HIV outcomes. Analyses were stratified by gender, direction of migration (into/out of household), and relationship between non-migrants and migrants (e.g., spouse).</p><p><strong>Results: </strong>There were 14,599 non-migrants (52% women) and 4,415 (30%) lived in a household with ≥1 migrant. Of these, 972 (22%) had migrant spouses, 1,102 (25%) migrant children, and 875 (20%) migrant siblings. Overall, HIV prevalence and viremia did not differ between non-migrants in households with and without migration. However, in stratified analyses, non-migrant women with migrant spouses were significantly more likely to be HIV seropositive compared to non-migrant women with non-migrant spouses (adjPR:1.44, 95%CI:1.21-1.71). Conversely, non-migrant mothers living with HIV who had migrant children were less likely to be viremic (adjPR:0.34, 95%CI:0.13-0.86).</p><p><strong>Conclusions: </strong>Non-migrating women with migrating spouses are more likely be living with HIV, and may benefit from additional HIV support services.</p>","PeriodicalId":14588,"journal":{"name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAIDS Journal of Acquired Immune Deficiency Syndromes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/QAI.0000000000003553","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: In Africa, migrants are more likely to be living with HIV and HIV viremic than non-migrants but less is known about HIV outcomes among non-migrants living in households with migrants. We compared HIV outcomes in non-migrating persons in households with and without migration.
Methods: We analyzed cross-sectional data collected between August 2016-May 2018 from non-migrating participants aged 15-49 in the Rakai Community Cohort Study in Uganda. Migrant households were classified as those reporting ≥1 member moving into or out of the household since the prior survey. HIV serostatus was determined using a validated testing algorithm, and viremia defined as >1,000 copies/mL. Modified Poisson regression was used to estimate prevalence ratios (PR) between household migration and HIV outcomes. Analyses were stratified by gender, direction of migration (into/out of household), and relationship between non-migrants and migrants (e.g., spouse).
Results: There were 14,599 non-migrants (52% women) and 4,415 (30%) lived in a household with ≥1 migrant. Of these, 972 (22%) had migrant spouses, 1,102 (25%) migrant children, and 875 (20%) migrant siblings. Overall, HIV prevalence and viremia did not differ between non-migrants in households with and without migration. However, in stratified analyses, non-migrant women with migrant spouses were significantly more likely to be HIV seropositive compared to non-migrant women with non-migrant spouses (adjPR:1.44, 95%CI:1.21-1.71). Conversely, non-migrant mothers living with HIV who had migrant children were less likely to be viremic (adjPR:0.34, 95%CI:0.13-0.86).
Conclusions: Non-migrating women with migrating spouses are more likely be living with HIV, and may benefit from additional HIV support services.
导言:在非洲,移民比非移民更有可能感染 HIV 和 HIV 病毒,但对于与移民生活在一起的家庭中的非移民的 HIV 感染情况却知之甚少。我们比较了有移民和无移民家庭中的非移民感染艾滋病的情况:我们分析了 2016 年 8 月至 2018 年 5 月间收集的横截面数据,这些数据来自乌干达拉凯社区队列研究中 15-49 岁的非移民参与者。迁移家庭被归类为自上次调查以来报告有≥1名成员迁入或迁出该家庭的家庭。艾滋病毒血清状态采用有效的检测算法确定,病毒血症的定义为 >1,000 拷贝/毫升。改良泊松回归用于估计家庭迁移与 HIV 感染结果之间的流行率 (PR)。分析按性别、迁移方向(迁入/迁出家庭)以及非移民与移民之间的关系(如配偶)进行分层:共有 14,599 名非移民(52% 为女性),4,415 人(30%)的家庭中移民人数≥1 人。其中,972人(22%)有移民配偶,1102人(25%)有移民子女,875人(20%)有移民兄弟姐妹。总体而言,在有移民和无移民的家庭中,非移民的艾滋病毒感染率和病毒血症没有差异。然而,在分层分析中,与配偶为非移民的非移民妇女相比,配偶为移民的非移民妇女的艾滋病毒血清呈阳性的可能性明显更高(adjPR:1.44, 95%CI:1.21-1.71)。相反,有移民子女的非移民母亲感染 HIV 病毒的几率较低(adjPR:0.34, 95%CI:0.13-0.86):结论:配偶为移民的非移民妇女感染 HIV 的可能性更大,可能会受益于额外的 HIV 支持服务。
期刊介绍:
JAIDS: Journal of Acquired Immune Deficiency Syndromes seeks to end the HIV epidemic by presenting important new science across all disciplines that advance our understanding of the biology, treatment and prevention of HIV infection worldwide.
JAIDS: Journal of Acquired Immune Deficiency Syndromes is the trusted, interdisciplinary resource for HIV- and AIDS-related information with a strong focus on basic and translational science, clinical science, and epidemiology and prevention. Co-edited by the foremost leaders in clinical virology, molecular biology, and epidemiology, JAIDS publishes vital information on the advances in diagnosis and treatment of HIV infections, as well as the latest research in the development of therapeutics and vaccine approaches. This ground-breaking journal brings together rigorously peer-reviewed articles, reviews of current research, results of clinical trials, and epidemiologic reports from around the world.